# Somatostatin Receptor Imaging in NPC, EBV Related Cancers

> **NCT05581550** · NA · COMPLETED · sponsor: **National Cancer Centre, Singapore** · enrollment: 15 (actual)

## Conditions studied

- Nasopharyngeal Cancer
- Epstein-Barr Virus Related Carcinoma

## Interventions

- **RADIATION:** FDG-PET
- **RADIATION:** Galium-68 DOTATATE

## Key facts

- **NCT ID:** NCT05581550
- **Lead sponsor:** National Cancer Centre, Singapore
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-29
- **Primary completion:** 2025-07-17
- **Final completion:** 2025-07-17
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05581550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05581550, "Somatostatin Receptor Imaging in NPC, EBV Related Cancers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05581550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*